Worsening of Chronic Heart Failure: Definition, Epidemiology, Management and Prevention. A Clinical Consensus Statement by the Heart Failure Association of the European Society of CardiologyMarco Metra, Giuseppe Rosano, Daniela Tomasoni et al.|European Journal of Heart Failure|2023Cited by 188
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Marianna Fontana, Yousuf Razvi et al.|Journal of the American College of Cardiology|2024Cited by 137
Pre-Discharge and Early Post-Discharge Management of Patients Hospitalized for Acute Heart Failure: A Scientific Statement by the Heart Failure Association of the ESCMarco Metra, Giuseppe Rosano, Marianna Adamo et al.|European Journal of Heart Failure|2023Cited by 92
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the <scp>AC‐TIVE</scp> study, an <scp>Italian nationwide survey</scp>Marco Merlo, Gianfranco Sinagra, Linda Pagura et al.|European Journal of Heart Failure|2022Cited by 91
Unusual arterial thrombotic events in Covid-19 patientsCharles de Roquetaillade, Alexandre Mebazaa, Benjamin G. Chousterman et al.|International Journal of Cardiology|2020Cited by 86